Related Experiment Videos
Dissolution dialysis studies of metronidazole-montmorillonite adsorbates
Journal of Pharmaceutical Sciences
|February 1, 1985
Summary
Clays like montmorillonite can control drug release. At acidic pH, montmorillonite inhibited metronidazole release, suggesting potential for targeted gastrointestinal amebiasis therapy.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Medicinal Chemistry
Background:
- Clays are being explored for controlled drug delivery applications.
- Montmorillonite clay's adsorption properties are of interest for drug formulation.
- Metronidazole is a key drug for treating amebiasis.
Purpose of the Study:
- To investigate the release kinetics of metronidazole from montmorillonite adsorbates.
- To evaluate the potential of montmorillonite for improving local gastrointestinal amebiasis therapy.
- To assess the influence of pH on drug release.
Main Methods:
- Dissolution dialysis studies were employed.
- Metronidazole was adsorbed onto montmorillonite.
- Drug release was monitored at different pH levels (acidic and neutral).
- Physical admixture of clay and drug was also tested.
Main Results:
- At acidic pH, montmorillonite exhibited a flocculated state, significantly inhibiting metronidazole release.
- Slow diffusion of metronidazole through the clay flocculate was identified as the inhibition mechanism.
- A physical admixture of montmorillonite and metronidazole also showed inhibited drug release.
- At pH 7, clay deflocculation led to a significant increase in the rate of metronidazole release.
Conclusions:
- Montmorillonite clay can effectively retard metronidazole release, particularly at acidic pH.
- This pH-dependent release control by montmorillonite holds promise for targeted gastrointestinal drug delivery.
- Further research could optimize clay-based formulations for enhanced amebiasis treatment.